perfluorobutane has been researched along with lenvatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, H; Kamachi, N; Koga, H; Kuromatsu, R; Nakano, M; Niizeki, T; Noda, Y; Okamura, S; Shimose, S; Shirono, T; Torimura, T | 1 |
1 other study(ies) available for perfluorobutane and lenvatinib
| Article | Year |
|---|---|
Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Liver Neoplasms; Male; Phenylurea Compounds; Prospective Studies; Protein Kinase Inhibitors; Quinolines; Ultrasonography | 2022 |